Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study-Reference-Cited by-全球学者库

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Published:2015-03-25 Issue:9 Volume:35 Page:2155-2166
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Park Joong‐Won¹,Chen Minshan²,Colombo Massimo³,Roberts Lewis R.⁴,Schwartz Myron⁵,Chen Pei‐Jer⁶,Kudo Masatoshi⁷,Johnson Philip⁸,Wagner Samuel⁹,Orsini Lucinda S.¹⁰,Sherman Morris¹¹

Affiliation:

1. Center for Liver Cancer National Cancer Center Goyang Korea

2. Sun Yat‐Sen University Cancer Center Guangzhou China

3. Policlinic IRCCS Maggiore Hospital University of Milan Milan Italy

4. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN USA

5. Mount Sinai Hospital New York NY USA

6. Taiwan National University Taipei Taiwan

7. Kinki University School of Medicine Osaka‐Sayama Osaka Japan

8. Birmingham University Birmingham UK

9. Bristol‐Myers Squibb Princeton NJ USA

10. Bristol‐Myers Squibb Wallingford CT USA

11. University of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.12818

Reference40 articles.

1. FerlayJ SoerjomataramI ErvikM et al.GLOBOCAN 2012 v1.0. Estimated cancer incidence mortality and prevalence worldwide. Available athttp://globocan.iarc.fr. Accessed 28 March 2014.

2. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

3. Hepatocellular carcinoma

4. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

5. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

Cited by 797 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy;World Journal of Gastrointestinal Oncology;2024-02-15

2. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study;Annals of Surgical Oncology;2024-02-05

3. Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway;Pharmacological Research;2024-02

4. Non-targeted metabolomics study for discovery of hepatocellular carcinoma serum diagnostic biomarker;Journal of Pharmaceutical and Biomedical Analysis;2024-02

5. Impact of body composition on the prognosis of hepatocellular carcinoma patients treated with transarterial chemoembolization: A systematic review and meta-analysis;Heliyon;2024-02